NEW YORK (GenomeWeb News) – Genomic Health's revenues for the first quarter increased 8 percent to $63.1 million from $58.5 million year over year, driven by increased use of its Oncotype DX products and significant growth in the use of its tests in markets outside of the US, the firm reported after the close of the market Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.